↓ Skip to main content

Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson’s disease

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson’s disease
Published in
Therapeutics and Clinical Risk Management, April 2013
DOI 10.2147/tcrm.s43811
Pubmed ID
Authors

Yoshihiro Sato, Jun Iwamaoto, Honda, Amano

Abstract

Vitamin D supplementation is suggested to reduce the risk of falls in older institutionalized or ambulatory individuals by 20%. The present study was undertaken to address the reduced risk, by vitamin D supplementation, of falls and hip fractures in patients with vascular Parkinsonism (VP) and Parkinson's disease (PD).

Twitter Demographics

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 22%
Student > Master 8 18%
Researcher 5 11%
Student > Ph. D. Student 5 11%
Other 2 4%
Other 4 9%
Unknown 11 24%
Readers by discipline Count As %
Medicine and Dentistry 16 36%
Nursing and Health Professions 6 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Agricultural and Biological Sciences 2 4%
Economics, Econometrics and Finance 1 2%
Other 3 7%
Unknown 15 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2013.
All research outputs
#6,925,573
of 22,708,120 outputs
Outputs from Therapeutics and Clinical Risk Management
#366
of 1,260 outputs
Outputs of similar age
#59,699
of 200,164 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#6
of 14 outputs
Altmetric has tracked 22,708,120 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,260 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,164 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.